Data as of 10:15am ET
| +0.03 / +0.07%|
Grifols SA operates as a fractionator of plasma derived blood products. The company operates through four segments: Bioessence, Hospital, Diagnostic and Raw Materials. The Bioessence segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by Group companies earmarked for hospital pharmacy. The Diagnostic segment includes the marketing of diagnostic testing equipment, reagents, and other equipment. The Raw Materials segment includes the sale of intermediate biological products and the rendering of manufacturing services to third party companies. The company applies sophisticated science and technology to improve people's health and well-being through providing life-saving products. The company was founded on June 22, 1987 and is headquartered in Barcelona, Spain.
|Víctor Grifols Roura||Chairman, President & Chief Executive Officer|
|Alfredo Arroyo Guerra||Chief Financial Officer & Vice President|
|Vicente Blanquer Torre||Technical Director & Vice President|
|Montserrat Lloveras Calvo||Director-Administration & Controller|
|Mary J. Kuhn||Executive Vice President|